U.S. FDA approval for Eliquis® (apixaban) to reduce risk of thrmobosis in Hip or Knee Replacement Surgery
Bristol-Myers Squibb Company and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery.

About Authors:
The first hospital associated with King George's Medical University was built in 1914, and was called King George Hospital. The funds allocated to the college could hardly be expected to cover the cost of a hospital on a comparable scale. Thus this task was undertaken by the Government of India. The building was again designed by Sir Swinton Jacob after making a spot study of great medical centres in Europe and adapting it the needs of this country.
New serendipitous discovery which may open a new concept of resisting bacteria from growing in body. Associate professor Aaron Oakley and his team reported that non-steroidal anti-inflammatory drugs (NSAIDs) are exhibit some antibacterial property and acting on DNA replication of bacteria.
